Full metadata record
DC FieldValueLanguage
dc.contributor.author施慧君zh_TW
dc.contributor.author徐作聖zh_TW
dc.contributor.authorShih, Hui-Chunen_US
dc.contributor.authorShyu, Joseph Z.en_US
dc.date.accessioned2018-01-24T07:42:56Z-
dc.date.available2018-01-24T07:42:56Z-
dc.date.issued2016en_US
dc.identifier.urihttp://etd.lib.nctu.edu.tw/cdrfb3/record/nctu/#GT070253506en_US
dc.identifier.urihttp://hdl.handle.net/11536/143082-
dc.description.abstract本研究應用創新密集服務分析模式架構,從內部服務價值活動與外部資源涵量為主體分析構面,來對醫學影像器材研發中介服務商之目前與未來策略定位進行評量分析。其中內部服務價值活動分析包含服務設計、測試認證、市場行銷、配銷活動、售後服務、支援活動等六大類核心關鍵因素的控制能力;而外部資源則強調互補資源、研究發展、產品設計、產品製造、服務提供、市場行銷、其他客戶等七大類外部資源關鍵因素的掌握程度,最後輔以四種客製化程度與五種創新方式所組成成的4x5 矩陣對兩大主體的差異分析,以了解未來(5~10年)的策略發展趨勢。IIS 的統計數據來源為產業專家的訪談及問卷結果。 研究結果顯示,由專家問卷與訪談所歸納的醫學影像器材研發中介服務商現在的策略定位為「產品創新( P1 )/一般型服務( G )」而未來的策略定位為「流程創新( P2)/選擇型服務(S )」。經IIS的分析後發現,此未來定位點的值大於μS +σS =1.326,表示這個策略未來定位的可行性具有一定的難度,應修正之;在不修正策略定位的情形下,建議未來廠商可考慮投入較多資源於服務價值活動與外部資源之補強建構上,或重新尋找新的策略定位,如「產品創新(P1)/選擇服務類型(S)」或「產品創新(P1)/專屬服務類型(U)」為較易完成策略與營運模式之轉型。zh_TW
dc.description.abstractBy applying an integrated model of Innovation Intensive Service ( IIS ), this thesis analyzes the current and future strategic positioning of R&D intermediation services in the medical imaging device industry from the aspect of internal value activities and externalities. The internal value activities comprise of 6 key factors, including Service Design, Validation of Testing, Marketing, Delivery, After Service and Supporting Activities, while the Externalities consist of 7 key factors, including Complementary Assets Supplier, R&D / Science, Technology, Production, Servicing, Market and Other Users. Through a 4x5 matrix, which encompasses four service approaches and five innovation modes, we elucidated the development trend of future (5-10 years) strategic positioning in this industry. The IIS statistics (assessment data) is derived from the data collected through interview with industry experts and questionnaires. The results showed that the PRESENT strategic positioning is focusing at “Product Innovation ( P1 )/General Service ( G )”; FUTURE at “Process Innovation ( P2 )/ Selective Service ( S )”. The IIS analysis revealed that both FUTURE strategic positioning as mentioned above are not feasible as the total score of internal value activities and externalities is greater than μS +σS =1.326. The study suggested R&D intermediation services providers of medical imaging devices invest more resources either to strengthen internal value activities and externalities, or reposition at “Product Innovation ( P1 )/ Selective Service ( S )” or “Product Innovation ( P1 )/Unique Service ( U )”, which is easier to achieve.en_US
dc.language.isozh_TWen_US
dc.subject醫學影像器材zh_TW
dc.subject研發中介zh_TW
dc.subject創新密集服務zh_TW
dc.subject知識密集服務業zh_TW
dc.subjectMedical Imaging Devicesen_US
dc.subjectR&D intermediationen_US
dc.subjectInnovation Intensive Servicesen_US
dc.subjectIISen_US
dc.subjectKnowledge Intensive Business Servicesen_US
dc.title醫學影像器材研發中介策略zh_TW
dc.titleAn R&D Intermediation Strategy of the Medical Imaging Devicesen_US
dc.typeThesisen_US
dc.contributor.department科技管理研究所zh_TW
Appears in Collections:Thesis